Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
McKesson
McKinsey
Colorcon
Merck

Last Updated: January 19, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Antipyrine


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Antipyrine?

Antipyrine is an investigational drug.

There have been 5 clinical trials for Antipyrine. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2011.

The most common disease conditions in clinical trials are Dysmenorrhea, Turner Syndrome, and Syndrome. The leading clinical trial sponsors are Merck Sharp & Dohme Corp., University of Aarhus, and Currax Pharmaceuticals.

Recent Clinical Trials for Antipyrine
TitleSponsorPhase
Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic AdultsGlobal United Pharmaceutical CorporationPhase 2
Four Arm Safety & Efficacy With Antipyrine and Benzocaine Otic Solution in Children With Acute Otitis MediaCurrax PharmaceuticalsPhase 2
Four Arm Safety & Efficacy With Antipyrine and Benzocaine Otic Solution in Children With Acute Otitis MediaPernix Theraputics LLCPhase 2

See all Antipyrine clinical trials

Clinical Trial Summary for Antipyrine

Top disease conditions for Antipyrine
Top clinical trial sponsors for Antipyrine

See all Antipyrine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
McKesson
McKinsey
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.